These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26705579)

  • 1. Relationship of hospital-associated bleeding with length of stay and total hospitalization costs in patients hospitalized for atrial fibrillation.
    Amin AN; Robinson SB; Bowdy BD; Jing Y; Johnson BH; Wiederkehr DP
    J Med Econ; 2016; 19(5):490-6. PubMed ID: 26705579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All-cause and bleeding-related health care costs in warfarin-treated patients with atrial fibrillation.
    Ghate SR; Biskupiak J; Ye X; Kwong WJ; Brixner DI
    J Manag Care Pharm; 2011 Nov; 17(9):672-84. PubMed ID: 22050392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incremental economic burden associated with major bleeding among atrial fibrillation patients treated with factor Xa inhibitors.
    Deitelzweig S; Neuman WR; Lingohr-Smith M; Menges B; Lin J
    J Med Econ; 2017 Dec; 20(12):1217-1223. PubMed ID: 28760063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily costs of hospitalization in non-valvular atrial fibrillation patients treated with anticoagulant therapy.
    Dasta JF; Pilon D; Mody SH; Lopatto J; Laliberté F; Germain G; Bookhart BK; Lefebvre P; Nutescu EA
    J Med Econ; 2015; 18(12):1041-9. PubMed ID: 26201251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Incremental Healthcare Economic Burden of Patients with Atrial Fibrillation Treated with Direct-Acting Oral Anticoagulants and Hospitalized for Major Bleeds in the USA.
    Deitelzweig SB; Lovelace B; Christoph M; Lingohr-Smith M; Lin J; Fermann GJ
    Adv Ther; 2020 Sep; 37(9):3942-3953. PubMed ID: 32699994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and cost of stroke and hemorrhage in patients diagnosed with atrial fibrillation in France.
    Cotté FE; Chaize G; Kachaner I; Gaudin AF; Vainchtock A; Durand-Zaleski I
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e73-83. PubMed ID: 24119623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of hospital length of stay between hospitalized non-valvular atrial fibrillation patients treated with either apixaban or warfarin.
    Farr AM; Jing Y; Johnston S; Trocio J; Singhal S; Bruno A; Graham J
    Hosp Pract (1995); 2015; 43(3):172-9. PubMed ID: 26213178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of atrial fibrillation and oral anticoagulation on hospital costs and length of stay.
    Song X; Sander SD; Johnson BH; Varker H; Amin AN
    Am J Health Syst Pharm; 2012 Feb; 69(4):329-38. PubMed ID: 22302258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalization.
    Bullano MF; Willey V; Hauch O; Wygant G; Spyropoulos AC; Hoffman L
    J Manag Care Pharm; 2005 Oct; 11(8):663-73. PubMed ID: 16194130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation: A Registry Study.
    Vestergaard AS; Skjøth F; Lip GY; Larsen TB
    Stroke; 2016 Apr; 47(4):979-85. PubMed ID: 26883499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital Admissions, Costs, and 30-Day Readmissions Among Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated with Dabigatran Etexilate or Warfarin.
    Fonseca E; Sander SD; Hess GP; Ghosh S
    J Manag Care Spec Pharm; 2015 Nov; 21(11):1039-53. PubMed ID: 26521116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The costs of warfarin underuse and nonadherence in patients with atrial fibrillation: a commercial insurer perspective.
    Casciano JP; Dotiwala ZJ; Martin BC; Kwong WJ
    J Manag Care Pharm; 2013 May; 19(4):302-16. PubMed ID: 23627576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of major bleeding in hospitalized patients with non-ST segment elevation acute coronary syndromes receiving injectable anticoagulants.
    Happe LE; Rao SV; Horblyuk R; Franklin M; Lunacsek OE; Menditto L
    Curr Med Res Opin; 2009 Feb; 25(2):413-20. PubMed ID: 19192986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the THERMOCOOL SMARTTOUCH catheter for ablation of atrial fibrillation: the relationship between hospital procedure volume, re-admissions, and economic outcomes.
    Barnow A; Goldstein L; Kalsekar I; Liao R; Khanna R
    J Med Econ; 2018 May; 21(5):481-487. PubMed ID: 29297705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major bleeding complications in a specialized anticoagulation service.
    Fanikos J; Grasso-Correnti N; Shah R; Kucher N; Goldhaber SZ
    Am J Cardiol; 2005 Aug; 96(4):595-8. PubMed ID: 16098319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of gastrointestinal bleeding among patients with atrial fibrillation after initiating dabigatran therapy.
    Lauffenburger JC; Rhoney DH; Farley JF; Gehi AK; Fang G
    Pharmacotherapy; 2015 Jun; 35(6):560-8. PubMed ID: 26044889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with length of hospitalization in patients admitted with transient ischemic attack in United States.
    Qureshi AI; Adil MM; Zacharatos H; Suri MF
    Stroke; 2013 Jun; 44(6):1601-5. PubMed ID: 23632974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hospital costs after minimally invasive versus open lumbar interbody fusion: data from a US national database with 6106 patients.
    Wang MY; Lerner J; Lesko J; McGirt MJ
    J Spinal Disord Tech; 2012 Aug; 25(6):324-8. PubMed ID: 21685806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning.
    Patel NJ; Deshmukh A; Pant S; Singh V; Patel N; Arora S; Shah N; Chothani A; Savani GT; Mehta K; Parikh V; Rathod A; Badheka AO; Lafferty J; Kowalski M; Mehta JL; Mitrani RD; Viles-Gonzalez JF; Paydak H
    Circulation; 2014 Jun; 129(23):2371-9. PubMed ID: 24842943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.